Related Experiment Video
Updated: Jan 15, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
Animal-derived ingredients in medicines: a framework for ethical prescribing practices
Hamdi Lababidi1, Christopher Bobier1, Daniel Rodger2
1Foundational Sciences, Central Michigan University College of Medicine, Mt Pleasant, United States.
None:
An increasing number of patients want to avoid animal-derived ingredients in medications due to ethical, religious, or cultural beliefs, yet transparency about these ingredients remains limited. Healthcare professionals often lack guidance on how to respect their preferences while ensuring effective treatment. Here, we propose an ethical pharmacotherapy modification framework that guides clinicians through a stepwise approach, altering manufacturer, dosage form, administration method, or medication itself, to accommodate patient values without compromising clinical efficacy. This framework balances respect for patient autonomy with clinical beneficence. Implementing this approach is likely to enhance patient trust and adherence by aligning pharmaceutical care with individual ethical considerations and promoting patient-centered care.
More Related Videos
Related Concept Videos
Ethics in Research
Preclinical Development: Overview
Clinically Relevant Drug Product Specifications: Methods of Establishment
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Drug Products: Biologics, Biosimilars and Interchangeables

